Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria and tetanus toxoids (GSK)
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tedivax-Adult is a bivalent vaccine containing purified diphtheria and tetanus toxoids adsorbed onto aluminum salts. It is indicated for active immunization against diphtheria and tetanus in individuals aged 7 years and older. The Adult (Td) formulation contains a reduced amount of diphtheria toxoid compared to pediatric (DT) vaccines to minimize the risk of adverse reactions in older populations who may have been previously sensitized. Developed by GSK, it is used both as a primary series component and as a booster dose every 10 years. In clinical research, it frequently serves as a reference control for evaluating the safety and immunogenicity of newer combination vaccines, such as those including acellular pertussis (Tdap).
- Brand names
- Tedivax-AdultTd-Rix
- Other names
- Td vaccineTetanus-diphtheria vaccine
02
Targets
Diphtheria toxinTT (Tetanus toxoid)
Beyond the preview
Go deeper on diphtheria and tetanus toxoids (GSK).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria and tetanus toxoids (GSK).